AU5744490A
(en)
*
|
1989-05-15 |
1990-12-18 |
Afferon Corporation |
Composition and method for neural desensitization
|
US5021450A
(en)
*
|
1989-05-30 |
1991-06-04 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
|
US5232684A
(en)
*
|
1990-06-29 |
1993-08-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Labelled resiniferatoxin, compositions thereof, and methods for using the same
|
ES2127729T3
(es)
*
|
1990-08-29 |
1999-05-01 |
Us Health |
Alimento para aves que contiene capsaicina o sus derivados o analogos.
|
US5629045A
(en)
*
|
1992-09-17 |
1997-05-13 |
Richard L. Veech |
Biodegradable nosiogenic agents for control of non-vertebrate pests
|
US6063381A
(en)
*
|
1993-05-19 |
2000-05-16 |
Staggs; Jeff J. |
Therapeutic uses of pungent botanicals and their related compounds
|
US6635659B1
(en)
*
|
1995-03-20 |
2003-10-21 |
Arrie Kegler |
Topical formulation for arthritic symptoms treatment
|
US6248788B1
(en)
|
1996-11-06 |
2001-06-19 |
The Regents Of The University Of California |
Therapeutic method with capsaicin and capasicin analogs
|
US6239180B1
(en)
|
1995-11-08 |
2001-05-29 |
The Regents Of The University Of California |
Transdermal therapeutic device and method with capsaicin and capsaicin analogs
|
US5869533A
(en)
*
|
1996-04-23 |
1999-02-09 |
Holt; Stephen D. |
Non-irritating capsaicin formulations and applicators therefor
|
US5856361A
(en)
*
|
1996-04-23 |
1999-01-05 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
EP0998275A4
(en)
*
|
1996-09-05 |
2003-05-02 |
Res Dev Foundation |
INHIBITION OF THE NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY THE PHENETHYLIC ESTER OF CAFEIC ACID, DERIVATIVES OF THIS ESTER, CAPSAICIN (8-METHYL-N-VANILLYLE-6-NONEAMIDE) AND RESINIFERATOXIN
|
WO1998020867A1
(en)
*
|
1996-11-15 |
1998-05-22 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
|
EP1201241B8
(en)
†
|
1997-03-13 |
2010-10-27 |
James N. Campbell |
Compositions containing capsaicin or capsaicin analogues and an anesthetic
|
JP2001513551A
(ja)
*
|
1997-08-28 |
2001-09-04 |
アフェロン コーポレイション |
尿失禁の治療
|
US6790207B2
(en)
|
1998-06-04 |
2004-09-14 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
|
US6802841B2
(en)
*
|
1998-06-04 |
2004-10-12 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US20110071468A1
(en)
*
|
1998-06-04 |
2011-03-24 |
Mederi Therapeutics, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US6653352B2
(en)
|
1999-09-29 |
2003-11-25 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US6197823B1
(en)
|
1999-09-29 |
2001-03-06 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US6348501B1
(en)
|
1999-09-29 |
2002-02-19 |
Medical Merchandising, Inc. |
Lotion compositions utilizing capsaicin
|
MXPA03000458A
(es)
*
|
2000-07-20 |
2004-06-02 |
Neurogen Corp |
Ligandos receptores de capsaicina.
|
US20040146590A1
(en)
*
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
US20060240125A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Astrup Arne V |
Composition for affecting weight loss
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
MXPA04006882A
(es)
*
|
2002-01-17 |
2004-12-06 |
Neurogen Corp |
Analogos substituidos de quinazolin-4-ilamina como moduladores de receptores de capsaicina.
|
US20040126430A1
(en)
|
2002-09-05 |
2004-07-01 |
Angel Arturo J. |
Compositions and kits for the removal of irritating compounds from bodily surfaces
|
EP2422772A3
(en)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
AU2003301190A1
(en)
*
|
2002-12-18 |
2004-07-14 |
Algorx |
Administration of capsaicinoids
|
CA2510181C
(en)
|
2002-12-18 |
2011-03-08 |
Algorx Pharmaceuticals, Inc. |
Administration of capsaicinoids
|
NZ542887A
(en)
*
|
2003-04-08 |
2008-05-30 |
Algorx Pharmaceuticals Inc |
Preparation and purification of synthetic capsaicin
|
US20040224037A1
(en)
*
|
2003-04-28 |
2004-11-11 |
Gonzalo Romero-Matos |
Devastating treatment against hiv/aids with capsaicin
|
WO2004112756A1
(en)
*
|
2003-06-26 |
2004-12-29 |
Isa Odidi |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
EP1827405A2
(en)
*
|
2004-11-24 |
2007-09-05 |
Algorx Pharmaceuticals, Inc. |
Capsaicinoid gel formulation and uses thereof
|
ES2533256T3
(es)
*
|
2004-12-28 |
2015-04-08 |
Mestex Ag |
Uso de resiniferatoxina (RTX) para la fabricación de un medicamento para el tratamiento del dolor
|
US9241502B2
(en)
*
|
2005-01-28 |
2016-01-26 |
Adm Alliance Nutrition |
Animal feed compositions capable of reducing the incidence of fescue toxicosis in mammals
|
PT1865941E
(pt)
*
|
2005-04-01 |
2011-01-05 |
Neurogesx Inc |
Óleos de capsaicinóides e métodos para a sua produção e utilização
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP2007222B1
(en)
*
|
2006-03-10 |
2017-05-03 |
Archer Daniels Midland Company |
Methods and compositions for increased productivity in animals
|
US9561188B2
(en)
*
|
2006-04-03 |
2017-02-07 |
Intellipharmaceutics Corporation |
Controlled release delivery device comprising an organosol coat
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
KR101486228B1
(ko)
|
2006-06-19 |
2015-01-26 |
알파마 파머슈티컬스 엘엘씨 |
약제학적 조성물
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
WO2008109026A1
(en)
*
|
2007-03-05 |
2008-09-12 |
Mt Cook Pharma |
Pharmaceutical compositions for the localized treatment of neurogenic dysfunction
|
US8170658B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
System for electrical modulation of neural conduction
|
US8165668B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
Method for magnetic modulation of neural conduction
|
US20090149799A1
(en)
*
|
2007-12-05 |
2009-06-11 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Method for chemical modulation of neural activity
|
US8165669B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
System for magnetic modulation of neural conduction
|
US8160695B2
(en)
|
2007-12-05 |
2012-04-17 |
The Invention Science Fund I, Llc |
System for chemical modulation of neural activity
|
US8195287B2
(en)
|
2007-12-05 |
2012-06-05 |
The Invention Science Fund I, Llc |
Method for electrical modulation of neural conduction
|
US8233976B2
(en)
|
2007-12-05 |
2012-07-31 |
The Invention Science Fund I, Llc |
System for transdermal chemical modulation of neural activity
|
US8180446B2
(en)
*
|
2007-12-05 |
2012-05-15 |
The Invention Science Fund I, Llc |
Method and system for cyclical neural modulation based on activity state
|
US8170660B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
System for thermal modulation of neural activity
|
US8987328B2
(en)
|
2008-10-30 |
2015-03-24 |
Trinity Laboratories, Inc. |
Esters of capsaicinoids as dietary supplements
|
US20100303932A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Baskaran Thyagarajan |
Method for Attenuating the Effects of Botulinum Toxin
|
US20110135627A1
(en)
*
|
2009-10-07 |
2011-06-09 |
The Inflasoothe Group, Inc. |
Pain relief composition, system and method
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2012012319A1
(en)
|
2010-07-19 |
2012-01-26 |
3M Innovative Properties Company |
Hand tool with replaceable knife cartridge
|
ES2647087T3
(es)
|
2010-07-27 |
2017-12-19 |
Flex Pharma, Inc. |
Métodos y composiciones para prevenir y aliviar los calambres musculares y para la recuperación de la irritabilidad neuromuscular y de la fatiga después del ejercicio
|
SG191288A1
(en)
|
2010-12-22 |
2013-07-31 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
WO2018136943A1
(en)
|
2017-01-23 |
2018-07-26 |
Flex Pharma, Inc. |
Compositions and methods affecting exercise performance
|
US11707437B2
(en)
|
2019-07-12 |
2023-07-25 |
Board Of Trustees Of Southern Illinois University |
Topical formulations with resiniferatoxin nanoparticles and methods
|